Las Vegas, NV -- (SBWIRE) -- 12/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Ambit Biosciences Corp (NASDAQ:AMBI), Cross Country Healthcare, Inc. (NASDAQ:CCRN), Athersys, Inc. (NASDAQ:ATHX)
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) managed to keep its gain at 30.09% on above-normal volume of 1.57M shares. The stock settled at $7.61 after floating in a range of $6.06 to $8.90. Its latest price has reached market capitalization of $28.53 million. Its 52-week range has been $2.25 to $15. Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system.
For How Long TNXP will fight for Profitability? Read This Trend Analysis report
Ambit Biosciences Corp (NASDAQ:AMBI) traded down on a volume of 1.55 million, higher than its standard daily volume. Shares have dropped-33.12% to $8.56. Over the last twelve months, the stock has gained 15.83% and faced a worst price of $6.22. Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML).
Has AMBI Found The Bottom And Ready To Gain Momentum? Find Out Here
Cross Country Healthcare, Inc. (NASDAQ:CCRN) settled -6.34% lower at $6.94 on above-normal volume of 1.54M shares during the last trading day. The stock has its 12-month high at $7.75 and 52-week low price was $4.05. It traded in a range of $6.90 to $7.50 during the last trading day. Cross Country Healthcare, Inc. (Cross Country) is engaged in the healthcare staffing services business offering a suite staffing and outsourcing services to the healthcare market. The Company segments include nurse and allied staffing, physician staffing, and other human capital management services.
Will CCRN Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Athersys, Inc. (NASDAQ:ATHX) was up on high volume, trading at a volume of 1.53M versus its average daily volume of 586,255.00 shares. At $2.20, the stock has attained market capitalization of 155.15 million. Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being evaluated in two ongoing Phase II clinical trials.
Will ATHX Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)